| Outcome Measures: |
Primary: Mean Hemoglobin Throughout the Trial and Mean Hemoglobin Change From Baseline Throughout the Trial., The Baseline hemoglobin was the mean of the four most recent mid- or end-of-week predialysis hemoglobin values collected prior to study start. Study start was the date of the first dose of peginesatide injection in participants who did not have a one-week transition period, or the date when Epoetin treatment was first withheld in participants who did have a one-week transition period., Baseline and Weeks 2-29 | Other: Proportion of Participants With Hemoglobin Within 1.0 g/dL Below Baseline to 1.5 g/dL Above Baseline Throughout the Trial (Weeks 2-29), Hemoglobin relative to baseline: Hemoglobin at a given time point was considered to be not within the specified range (within 1 g/dL below to 1.5 g/dL above baseline) if the hemoglobin value at the time point was not within the range and the next available hemoglobin value within 14 days after the time point also was not within the specified range. These calculations were determined for all time points within a specified time period., Weeks 2 to 29|Proportion of Participants Who Maintained Hemoglobin Within 10 to 12.5 g/dL Throughout the Trial, Hemoglobin relative to baseline: Hemoglobin at a given time point was considered to be not within the specified range (within the range of 10 g/dL to 12.5 g/dL) if the hemoglobin value at the time point was not within the range and the next available hemoglobin value within 14 days after the time point also was not within the specified range. These calculations were determined for all time points within a specified time period., Weeks 2 to 29|Proportion of Participants Who Maintain Hemoglobin Within 9.5 to 13.0 g/dL Throughout the Trial, Hemoglobin relative to baseline: Hemoglobin at a given time point was considered to be not within the specified range (within the range of 9.5 g/dL to 13.0 g/dL) if the hemoglobin value at the time point was not within the range and the next available hemoglobin value within 14 days after the time point also was not within the specified range. These calculations were determined for all time points within a specified time period., Weeks 2 to 29
|
| Locations: |
Research Facility, Burgas, 8000, Bulgaria|Research Facility, Pleven, 5800, Bulgaria|Research Facility, Plovdiv, 4003, Bulgaria|Research Facility, Rousse, 7002, Bulgaria|Research Facility, Sofia, 1527, Bulgaria|Research Facility, Sofia, 1606, Bulgaria|Research Facility, Sofia, 1709, Bulgaria|Research Facility, Varna, 9010, Bulgaria|Research Facility, Veliko Tarnovo, 5000, Bulgaria|Research Facility, Arad, 310017, Romania|Research Facility, Bacau, 600114, Romania|Research Facility, Bucuresti, Romania|Research Facility, Iasi, 700503, Romania|Research Facility, Timisoara, 300736, Romania|Research Facility, London, SE5 9RS, United Kingdom
|
